Connor, Clark & Lunn Investment Management (CC&L)’s TG Therapeutics TGTX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-144,648
| Closed | -$2.57M | – | 1638 |
|
|
2024
Q2 | $2.57M | Sell |
144,648
-87,699
| -38% | -$1.56M | 0.01% | 588 |
|
|
2024
Q1 | $3.53M | Sell |
232,347
-113,857
| -33% | -$1.73M | 0.02% | 508 |
|
|
2023
Q4 | $5.91M | Buy |
+346,204
| New | +$5.91M | 0.03% | 377 |
|
|
2023
Q3 | – | Sell |
-327,606
| Closed | -$8.14M | – | 1538 |
|
|
2023
Q2 | $8.14M | Buy |
+327,606
| New | +$8.14M | 0.04% | 296 |
|
|
2021
Q3 | – | Sell |
-18,815
| Closed | -$730K | – | 1214 |
|
|
2021
Q2 | $730K | Buy |
+18,815
| New | +$730K | ﹤0.01% | 718 |
|
|
2021
Q1 | – | Sell |
-24,516
| Closed | -$1.28M | – | 1091 |
|
|
2020
Q4 | $1.28M | Buy |
+24,516
| New | +$1.28M | 0.01% | 592 |
|
|
2020
Q2 | – | Sell |
-40,103
| Closed | -$395K | – | 1167 |
|
|
2020
Q1 | $395K | Buy |
+40,103
| New | +$395K | ﹤0.01% | 749 |
|